[Anticholinesterase effect of calcium channel blockers: diltiazem, verapamil, and nifedipine].
Ivanov
Iu Ia
IuIa
D000110:Acetylcholinesterase / Q000097:blood; D000818:Animals; D002091:Butyrylcholinesterase / Q000097:blood; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004110:Diltiazem / Q000494:pharmacology*; D006736:Horses; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D009543:Nifedipine / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology*
D002121:Calcium Channel Blockers; D002800:Cholinesterase Inhibitors; D014700:Verapamil; D000110:Acetylcholinesterase; D002091:Butyrylcholinesterase; D004110:Diltiazem; D009543:Nifedipine
Antikholinésteraznoe deĭstvie blokatorov kal'tsievykh kanalov: diltiazema, verapamila i nifedipina.